December 8, 2014
Pfizer Japan launched its chronic myeloid leukemia (CML) drug Bosulif Tablets 100 mg (bosutinib) on December 5. The drug is indicated for CML patients who were resistant or intolerant to previous treatments. Its peak sales are expected to reach 5.4...read more